Long-term results of radiotherapy for early-stage testicular seminoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 2, 2005, Pages 119-124

  Garcia Serra, Allie M ^a   Zlotecki, Robert A ^a,b   Morris, Christopher G ^a   Amdur, Robert J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Radiotherapy; Seminoma; Treatment outcome

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; AGED; AORTA; ARTICLE; BASAL CELL CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CHONDROSARCOMA; CLAVICLE; CORONARY ARTERY DISEASE; ERECTILE DYSFUNCTION; FOLLOW UP; GASTROINTESTINAL REFLUX; HEAD AND NECK CARCINOMA; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MELANOMA; METASTASIS; OUTCOMES RESEARCH; PELVIS; PEPTIC ULCER; PROSTATE CANCER; SECOND CANCER; SEMINOMA; SEXUAL DYSFUNCTION; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TESTIS CANCER; THYROID CANCER; THYROID PAPILLARY CARCINOMA; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; SEMINOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 17044427086     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000143843.08585.ce     Document Type: Article

References (39)

1. Lederman GS, Sheldon TA, Chaffey JT, et al. Cardiac disease after mediastinal irradiation for seminoma. Cancer. 1987;60:772-774.
2. Einhorn LH. Radiotherapy in seminoma: more is not better. Int J Radiat Oncol Biol Phys. 1982;8:309-310.
3. Peckham MJ, McElwain TJ. Radiotherapy of testicular tumors. Proc R Soc Med. 1974;67:300-303.
4. Thomas GM, Rider WD, Dembo AJ, et al. Seminoma of the testis: results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys. 1982;8:165-174.
5. Dosoretz DE, Shipley WU, Blitzer PH, et al. Megavoltage irradiation for pure testicular seminoma: results and patterns of failure. Cancer. 1981;48:2184-2190.
6. Fossa SD, Horwich A, Russell JM, et al. Optimal planning target volume for stage I testicular seminoma: a medical research council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol. 1999;17:3004-3005.
7. Dieckmann K, Bruggeboes B, Pichlmeier U, et al. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology. 2000;55:102-106.
8. Reiter WJ, Brodowicz T, Alavi S, et al. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma. J Clin Oncol. 2001;19:101-104.
9. SAS OnlineDoc, version 8. Cary, NC: SAS Institute Inc; 1999.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Cox DR. Regression models and life tables-series B (methodological). J R Stat Soc. 1972;34:187-220.
12. Hanks GE, Peters T, Owen J. Seminoma of the testis: long-term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys. 1992;24:913-919.
13. Fleshner N, Warde P. Controversies in the management of testicular seminoma. Semin Urol Oncol. 2002;20:227-233.
14. Warde P, Gospodarowicz MK, Panzarella T, et al. Long term outcomes and cost in the management of stage I testicular seminoma. Can J Urol. 2000;7:967-972.
15. Sharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol. 1996;14:2933-2939.
16. Horwich A, Alsanjari N, A'Hem R, et al. Surveillance following orchidectomy for stage I testicular cancer. Br J Cancer. 1992;65:775-778.
17. Fiveash J, Sandler HM. Controversies in the management of stage I seminoma. Oncology (Huntingt). 1998;12:1203-1212.
18. Oliver RT, Edmonds PM, Ong JY, et al. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage 1 seminoma: should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys. 1994;29:3-8.
19. Hamilton CR, Horwich A, Bliss JM, et al. Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis. Radiother Oncol. 1987;10:85-90.
20. Hamilton C, Horwich A, Easton D, et al. Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol. 1986;6:115-120.
21. Vallis KA, Howard GC, Duncan W, et al. Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients. Br J Radiol. 1995;68:400-405.
22. Fossa SD, Aass N, Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys. 1989;16:383-388.
23. Akimoto T, Takahashi I, Takahashi M, et al. Long-term outcome of postorchiectomy radiation therapy for stage I and II testicular seminoma. Anticancer Res. 1997;17:3781-3785.
24. Whitaker M. Proton pump inhibitors in the elderly population. Eur J Gastroenterol Hepatol. 2002;14:S5-S9.
25. Achem AC, Achem SR, Stark ME, et al. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol. 2003;98:35-39.
26. Incrocci L, Hop WC, Wijnmaalen A, et al. Treatment outcome, body image, and sexual functioning after orchidectomy and radiotherapy for stage I-II testicular seminoma. Int J Radiat Oncol Biol Phys. 2002;53:1165-1173.
27. Blackmore C. The impact of orchidectomy upon the sexuality of the man with testicular cancer. Cancer Nurs. 1988;11:33-40.
28. van Basten JP, Jonker-Pool G, van Driel MF, et al. Fantasies and facts of the testes. Br J Urol. 1996;78:756-762.
29. Schover LR, Gonzales M, von Eschenbach AC. Sexual and marital relationships after radiotherapy for seminoma. Urology. 1986;27:117-123.
30. Caffo O, Amichetti M. Evaluation of sexual life after orchidectomy followed by radiotherapy for early-stage seminoma of the testis. BJU Int. 1999;83:462-468.
31. McReynolds RA, Gold GL, Roberts WC. Coronary heart disease after mediastinal irradiation for Hodgkin's disease. Am J Med. 1976;60:39-45.
32. Boivin JF, Hutchison GB. Coronary heart disease mortality after irradiation for Hodgkin's disease. Cancer. 1982;49:2470-2475.
33. LaMonte CS, Yeh SD, Straus DJ. Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin. Cancer Treat Rep. 1986;70:439-444.
34. Polliack A. Late therapy-induced cardiac and pulmonary complications in cured patients with Hodgkin's disease treated with conventional combination chemo-radiotherapy. Leak Lymphoma. 1995;15:7-10.
35. Mauch PM, Kalish LA, Marcus KC, et al. Long-term survival in Hodgkin's disease: relative impact of mortality, second tumors, infection and cardiovascular disease. Cancer J Sci Am. 1995;1:33.
36. Hancock SL, Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol. 1996;6:225-242.
37. Adams MJ, Hardenbergh P, Constine LS, et al. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol. 2003;45:55-75.
38. Chao CK, Lai PP, Michalski JM, et al. Secondary malignancy among seminoma patients treated with adjuvant radiation therapy. Int J Radial Oncol Biol Phys. 1995;33:831-835.
39. Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst. 1997;89:1429-1439.